Jci_page_head_homepage_01 Jci_page_head_homepage_02
Masayuki Mori, Guixin Li, Ikuro Abe, Jun Nakayama, Zhanjun Guo, Jinko Sawashita, Tohru Ugawa, Shoko Nishizono, Tadao Serikawa, Keiichi Higuchi, Seigo Shumiya
Published in Volume 116, Issue 2
J Clin Invest. 2006; 116(2):395–404 doi:10.1172/JCI20797
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 4
Exon truncation due to a G→A substitution in exon 4 of the rat Lss gene.

(A) Exon and intron sequences are indicated by upper- and lower-case letters, respectively. The A substitution in exon 4 is indicated in bold. The 47 bases deleted by the exon truncation are in parentheses. Also shown are the normal (bottom) and aberrant (top) mRNA sequences and the predicted amino acids. The asparagine substitution at residue 139 is indicated in bold. (B) Agarose gel image of RT-PCR products for Lss mRNA derived from the livers and lenses of SCR and ACI rats as well as minigene constructs. (C) Measurement of aberrant splicing by in vitro transcription of rat Lss minigene constructs. Left: Schematic illustrations of the Lss minigene constructs. Only inserts in the pEF6/V5-His-TOPO vector are shown. Exons, introns, and primers are not to scale. Arrows indicate oligonucleotide primers. Right: Electropherograms of RT-PCR products from each construct. Peak area values and percentages of total are shown for aberrant and normally spliced products.